½ÃÀ庸°í¼­
»óǰÄÚµå
1597120

ºÏ¹ÌÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀå ¿¹Ãø : Áö¿ªº° ºÐ¼®-Á¦Ç°º°, ÃÖÁ¾ »ç¿ëÀÚº°(-2031³â)

North America Blood Gas and Electrolyte Analyzer Market Forecast to 2031 - Regional Analysis - by Product and End User

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Insight Partners | ÆäÀÌÁö Á¤º¸: ¿µ¹® 72 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ºÏ¹ÌÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀåÀº 2023³â 9¾ï 3,697¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2031³â±îÁö´Â 14¾ï 502¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2023³âºÎÅÍ 2031³â±îÁö CAGRÀº 5.2%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

º´¿ø ÀÀ±Þ½Ç¿¡¼­ ȯÀÚ¼ö°¡ Áõ°¡°¡ ºÏ¹ÌÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀåÀ» Ȱ¼ºÈ­

´ç´¢º´, ¾Ï, ½ÉÀ庴 ¹× ±âŸ ¸¸¼º ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó º´¿øÀÇ ÀÀ±Þ½Ç(ER)ÀÇ Çʿ伺ÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. º´¿øÀÇ ÀÀ±Þ½ÇÀº ½É°¢ÇÑ ¸¸¼º ÁúȯÀ» ¾Î°í ÀÖÀ¸¸ç ½Ã±ÞÇÑ Ä¡·á¿Í ÀÇ·á °³ÀÔÀÌ ÇÊ¿äÇÑ È¯ÀÚ¿¡°Ô ÇʼöÀûÀÎ ÀÇ·á ¼­ºñ½º¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¼­ºñ½º´Â º¹ÀâÇÏ¸ç °¢ ÆÄÆ®°¡ Ä¡·á¸¦ Á¦°øÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ÀÀ±Þ ÀÇ·á ¼­ºñ½ºÀÇ Ã¹ ¹øÂ° ¸ñÀûÀº ³»°úÀû, ¿Ü°úÀû, »ê°úÀû ¹®Á¦¸¦ Áï½Ã Ä¡·áÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÀ±Þ º´¿øÀÇ ÀÀ±Þ½Ç¿¡¼­ Ä¡·á¸¦ ¿ä±¸Çϴ ȯÀÚ Áõ°¡´Â Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ¼ö¿ä¿¡ ±àÁ¤Àû ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é ¼¼°è ¿¬°£ ¾à 1¾ï 5,000¸¸ ¸íÀÇ È¯ÀÚ°¡ º´¿øÀÇ ÀÀ±Þ½ÇÀ» ¹æ¹®Çϰí ÀÖ½À´Ï´Ù. 2023³â CDC°¡ ¹ßÇ¥ÇÑ µ¥ÀÌÅÍ¿¡ µû¸£¸é ¹Ì±¹¿¡¼­´Â ¿¬°£ ¾à 1¾ï 3,980¸¸ °ÇÀÇ ER ÁøÂûÀÌ ±â·ÏµÇ¾ú½À´Ï´Ù. ¶ÇÇÑ Ä¶¸®Æ÷´Ï¾Æ ÁÖ¿¡¼­´Â 2011³âºÎÅÍ 2021³â±îÁö ED ÁøÂûÀÚ°¡ 7.4% Áõ°¡Çß½À´Ï´Ù. ÀÀ±Þ ¿Ü·¡¿¡¼­´Â ÁßÁõ ȯÀÚ¸¦ ½Å¼ÓÇϰí Á¤È®ÇÏ°Ô Æò°¡ÇØ¾ß ÇÏ´Â ¾Ð·ÂÀÌ ³ô¾ÆÁö°í ÀÖÀ¸¸ç, Ç÷¾×°¡½º °ª, ÀüÇØÁú ¼öÁØ, »ê¿°±â ÆòÇü¿¡ ´ëÇÑ Àû½Ã Áø´Ü Á¤º¸°¡ °¡Àå Áß¿äÇØÁö°í ÀÖ½À´Ï´Ù. Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â´Â È£Èí °ï¶õ, ´ë»ç ÀÌ»ó, ½É°¢ÇÑ »óÅ¿¡ Àִ ȯÀÚ¸¦ Æò°¡ ¹× °ü¸®Çϱâ À§ÇÑ Áø´Ü µ¥ÀÌÅ͸¦ ±× ÀÚ¸®¿¡¼­ Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®±â°¡ ȯÀÚÀÇ »ê¼ÒÈ­ »óÅÂ, »ê¿°±â ÆòÇü, ÀüÇØÁú ¼öÁØÀ» ½Ç½Ã°£À¸·Î ÆÄ¾ÇÇÒ ¼ö ÀÖ´Â °ÍÀº ±¸±Þ ÇöÀå¿¡¼­ÀÇ ¼Ò»ý Á¶Ä¡ÀÇ ÁöħÀÌ µÇ¾î ÀÓ»ó °á°ú¸¦ ÃÖÀûÈ­Çϴµ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù.

ÀÀ±ÞÄ¡·á½Ç¿¡¼­ÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ȯÀÚÀÇ Ä§´ë »çÀ̵忡¼­ ½Å¼ÓÇÑ °Ë»ç¸¦ °¡´ÉÇÏ°Ô ÇÏ´Â ÈÞ´ëÇüÀ̳ª Æ÷ÀÎÆ® ¿Àºê ÄÉ¾î ±â±â µîÀÇ ±â¼úÀÇ Áøº¸¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÄÄÆÑÆ®ÇÑ ºÐ¼®±â´Â ¿öÅ©Ç÷οìÀÇ È¿À²¼ºÀ» ³ôÀÌ°í ½Å¼ÓÇÑ Áø´Ü ¹× Ä¡·á °³½Ã¸¦ ÃËÁøÇÔÀ¸·Î½á ȯÀÚÀÇ °á°ú¸¦ °³¼±ÇÕ´Ï´Ù. º´¿øÀÌ È¯ÀÚ¼öÀÇ Áõ°¡¿¡ ´ëÀÀÇϱâ À§Çؼ­ ±¸±Þ ÀÇ·á ¼­ºñ½ºÀÇ Ãæ½ÇÀ» ¿ì¼±½ÃŰ´Â °¡¿îµ¥, Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀå¿¡¼­´Â, ±¸±Þ ÀǷᳪ ÁßÁõ ȯÀÚ¸¦ ´ë»óÀ¸·Î ÇÑ ±â¼úÀûÀ¸·Î ¼±ÁøÀûÀÎ ¼Ö·ç¼ÇÀÇ Ã¤¿ëÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

ºÏ¹ÌÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀå °³¿ä

ºÏ¹ÌÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀåÀº ¹Ì±¹, ij³ª´Ù, ¸ß½ÃÄÚ·Î ±¸ºÐµË´Ï´Ù. 2023³â ºÏ¹ÌÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀåÀº ¹Ì±¹ÀÌ ÃÖ´ë Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. ¼ºÀåÀÇ ¿øµ¿·ÂÀº ½ÉÇ÷°üÁúȯ¿¡ ´ëÇÑ ÀÏ¹Ý ½Ã¹ÎÀÇ ÀÇ½Ä °íÁ¶¿Í Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀå¿¡¼­ÀÇ Çõ½ÅÀûÀÎ Ä¡·á ¿ëµµÀ» ޱ¸Çϱâ À§ÇÑ ¿¬±¸¿Í Çù·ÂÀÇ È®´ëÀÔ´Ï´Ù. ºÏ¹ÌÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â °Ë»ç ŰƮ ½ÃÀåÀº ÀÌ ½ÃÀå¿¡ ´Ù¾çÇÑ ÁÖ¿ä ±â¾÷µéÀÇ Á¸Àç·Î ÀÎÇØ °¡¼Óµµ°¡ ºÙÀ» °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¶Ç, ÇコÄɾîÀÇ ÁúÀÇ Çâ»ó°ú ºñ¿ë »è°¨À» ¸ñÀûÀ¸·Î ÇÑ ÀÇ·á ±â±âÀÇ µµÀÔÀÌ, µ¿Áö¿ªÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

ºÏ¹ÌÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀå ¼öÀÍ ¹× ¿¹Ãø(±Ý¾×)(-2031³â)

ºÏ¹ÌÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀå ¼¼ºÐÈ­

ºÏ¹ÌÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀåÀº Á¦Ç°, ÃÖÁ¾ »ç¿ëÀÚ, ±¹°¡·Î ºÐ·ùµË´Ï´Ù.

Á¦Ç°º°·Î´Â ºÏ¹ÌÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀåÀº Ç÷¾×°¡½º ºÐ¼®±â, ÀüÇØÁú ºÐ¼®±â, º¹ÇÕ ºÐ¼®±â, ±âŸ·Î ºÐ·ùµË´Ï´Ù. 2023³â¿¡´Â º¹ÇÕ ºÐ¼®±â°¡ ÃÖ´ë ½ÃÀå Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

ÃÖÁ¾ »ç¿ëÀÚº°·Î´Â ºÏ¹ÌÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀåÀº º´¿ø ¹× Áø·á¼Ò, ÀÓ»ó ¹× Áø´Ü°Ë»ç½Ç, ÀçÅÃÀÇ·á, ±âŸ·Î ±¸ºÐµË´Ï´Ù. 2023³â¿¡´Â ÀÓ»ó ¹× Áø´Ü°Ë»ç½Ç ºÎ¹®ÀÌ ÃÖ´ë ½ÃÀåÁ¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù..

±¹°¡º°·Î´Â ºÏ¹ÌÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀåÀº ¹Ì±¹, ij³ª´Ù, ¸ß½ÃÄÚ·Î ±¸ºÐµË´Ï´Ù. 2023³â ºÏ¹ÌÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀå Á¡À¯À²Àº ¹Ì±¹ÀÌ µ¶Á¡Çß½À´Ï´Ù.

Abbott Laboratories, Dalko Diagnostics Private Limited, Erba Diagnostics Mannheim GmbH, Hoffmann-La Roche Ltd, Medica Corporation, Nova Biomedical Corporation, Siemens Healthineers AG, Werfen SA, Radiometer Medical ApS, Sensa Core Medical Instrumentation Pvt Ltd.´Â ºÏ¹ÌÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀå¿¡¼­ »ç¾÷À» Àü°³Çϰí ÀÖ´Â ÁÖ¿ä ±â¾÷ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ÁÖ¿ä ÀλçÀÌÆ®

Á¦3Àå Á¶»ç ¹æ¹ý

  • Á¶»ç ¹üÀ§
  • 2Â÷ Á¶»ç
  • 1Â÷ Á¶»ç

Á¦4Àå ºÏ¹ÌÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀå : ÁÖ¿ä ½ÃÀå ¿ªÇÐ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • º´¿øÀÇ ±¸±Þ À¯´Ö¿¡¼­ÀÇ È¯ÀÚ¼ö Áõ°¡
    • POC(Point of Care) Áø´ÜÀÇ Ã¤¿ë Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ºÐ¼®±âÀÇ °íºñ¿ë
  • ½ÃÀå ±âȸ
    • ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ
  • ÇâÈÄÀÇ µ¿Çâ
    • Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±âÀÇ ÀÚµ¿È­ ¹× ÀΰøÁö´ÉÈ­
  • ¼ºÀå ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎÀÇ ¿µÇâ

Á¦5Àå ºÏ¹ÌÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀå ºÐ¼®

  • ºÏ¹ÌÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀå ¼öÀÍ(2021-2031³â)
  • Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀå ¿¹Ãø ºÐ¼®

Á¦6Àå ºÏ¹ÌÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀå ºÐ¼® : Á¦Ç°º°

  • Ç÷¾×°¡½º ºÐ¼®±â
  • ÀüÇØÁú ºÐ¼®±â
  • º¹ÇÕ ºÐ¼®±â
  • ±âŸ

Á¦7Àå ºÏ¹ÌÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀå ºÐ¼® : ÃÖÁ¾ »ç¿ëÀÚº°

  • º´¿ø ¹× Áø·á¼Ò
  • ÀÓ»ó ¹× Áø´Ü ½ÇÇè½Ç
  • ÀçÅÃÄ¡·á
  • ±âŸ

Á¦8Àå ºÏ¹ÌÀÇ Ç÷¾×°¡½º ¹× ÀüÇØÁú ºÐ¼®±â ½ÃÀå : ±¹°¡º° ºÐ¼®

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ

Á¦9Àå ¾÷°è Á¤¼¼

  • À¯±âÀû ¼ºÀå Àü·«
  • ºê·£µå Á¡À¯À² ¹× ¼öÀÍ(2022³â)

Á¦10Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • Abbott Laboratories
  • Dalko Diagnostics Private Limited
  • Erba Diagnostics Mannheim GmbH
  • Hoffmann-La Roche Ltd
  • Medica Corporation
  • Nova Biomedical Corporation
  • Siemens Healthineers AG
  • Werfen SA
  • Radiometer Medical ApS
  • Sensa Core Medical Instrumentation Pvt Ltd

Á¦11Àå ºÎ·Ï

AJY 24.12.05

The North America blood gas and electrolyte analyzer market was valued at US$ 936.97 million in 2023 and is projected to reach US$ 1,405.02 million by 2031; it is estimated to record a CAGR of 5.2% from 2023 to 2031.

Increasing Number of Patients in Emergency Units of Hospitals Fuels North America Blood Gas and Electrolyte Analyzer Market

The rising prevalence of diabetes, cancer, heart disease, and other chronic conditions propels the requirement for hospital emergency rooms (ER). Hospital emergency rooms offer vital medical care for patients affected by severe chronic conditions who need immediate attention and medical intervention. These services are complex, with each part being crucial to providing care. The primary objective of emergency medical services is immediately treating medical, surgical, and obstetric problems. The increasing number of patients seeking care in emergency hospital emergency units positively impacts the demand for blood gas and electrolyte analyzers. According to the World Health Organization (WHO), around 150 million patients visit hospital emergency rooms across the world annually. The US records about 139.8 million ER visits per year, according to data released by the CDC in 2023. In addition, there was a 7.4% rise in ED visits in California between 2011 and 2021. As emergency departments face mounting pressure to deliver rapid and accurate assessments of critically ill patients, timely diagnostic information on blood gas values, electrolyte levels, and acid-base balance becomes paramount. Blood gas and electrolyte analyzers provide on-the-spot diagnostic data for evaluating and managing patients affected by respiratory distress, metabolic abnormalities, or critical conditions. The ability of these analyzers to provide real-time insights into a patient's oxygenation status, acid-base equilibrium, and electrolyte levels is crucial for guiding resuscitative measures and optimizing clinical outcomes in emergency settings.

The growing demand for blood gas and electrolyte analyzers in emergency units drives advancements in technology, such as portable and point-of-care devices, that enable rapid testing at the patient's bedside. These compact analyzers enhance workflow efficiency and improve patient outcomes by facilitating prompt diagnosis and treatment initiation. As hospitals prioritize enhancing emergency care services to meet the needs of a rising patient population, the blood gas and electrolyte analyzers market is witnessing increased adoption of technologically advanced solutions tailored to the urgent and critical care setting.

North America Blood Gas and Electrolyte Analyzer Market Overview

The North America blood gas and electrolyte analyzer market has been segmented into the US, Canada, and Mexico. The US held the largest share of the North America blood gas and electrolyte analyzer market in 2023. The growth is driven by increasing public awareness regarding cardiovascular diseases and growing research and collaboration to explore innovative therapeutic applications in the blood gas and electrolyte analyzer market. The market for blood gas and electrolyte analyzer test kits in North America is projected to spur with the presence of various key players in the market. In addition, the adoption of medical devices in healthcare operations for improving quality and reducing costs augments the growth of the blood gas and electrolyte analyzer market in the region.

North America Blood Gas and Electrolyte Analyzer Market Revenue and Forecast to 2031 (US$ Million)

North America Blood Gas and Electrolyte Analyzer Market Segmentation

The North America blood gas and electrolyte analyzer market is categorized into product, end user, and country.

Based on product, the North America blood gas and electrolyte analyzer market is categorized into blood gas analyzer, electrolyte analyzer, combined analyzer, and others. The combined analyzer segment held the largest market share in 2023.

By end user, the North America blood gas and electrolyte analyzer market is segmented into hospitals and clinics, clinical and diagnostic laboratories, homecare, and others. The clinical and diagnostic laboratories segment held the largest market share in 2023.

By country, the North America blood gas and electrolyte analyzer market is segmented into the US, Canada, and Mexico. The US dominated the North America blood gas and electrolyte analyzer market share in 2023.

Abbott Laboratories, Dalko Diagnostics Private Limited, Erba Diagnostics Mannheim GmbH, Hoffmann-La Roche Ltd, Medica Corporation, Nova Biomedical Corporation, Siemens Healthineers AG, Werfen SA, Radiometer Medical ApS, and Sensa Core Medical Instrumentation Pvt Ltd. are some of the leading companies operating in the North America blood gas and electrolyte analyzer market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Blood Gas and Electrolyte Analyzer Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Increasing Number of Patients in Emergency Units of Hospitals
    • 4.1.2 Rising Adoption of Point-of-Care Diagnostics
  • 4.2 Market Restraints
    • 4.2.1 High Costs of Analyzers
  • 4.3 Market Opportunities
    • 4.3.1 New Product Launches and Approvals
  • 4.4 Future Trends
    • 4.4.1 Automation and Artificial Intelligence in Blood Gas and Electrolyte Analyzer
  • 4.5 Impact of Drivers and Restraints:

5. Blood Gas and Electrolyte Analyzer Market - North America Analysis

  • 5.1 North America Blood Gas and Electrolyte Analyzer Market Revenue (US$ Million), 2021-2031
  • 5.2 Blood Gas and Electrolyte Analyzer Market Forecast Analysis

6. North America Blood Gas and Electrolyte Analyzer Market Analysis - by Product

  • 6.1 Blood Gas Analyzer
    • 6.1.1 Overview
    • 6.1.2 Blood Gas Analyzer: Blood Gas and Electrolyte Analyzer Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.2 Electrolyte Analyzer
    • 6.2.1 Overview
    • 6.2.2 Electrolyte Analyzer: Blood Gas and Electrolyte Analyzer Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.3 Combined Analyzer
    • 6.3.1 Overview
    • 6.3.2 Combined Analyzer: Blood Gas and Electrolyte Analyzer Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.4 Others
    • 6.4.1 Overview
    • 6.4.2 Others: Blood Gas and Electrolyte Analyzer Market - Revenue and Forecast to 2031 (US$ Million)

7. North America Blood Gas and Electrolyte Analyzer Market Analysis - by End User

  • 7.1 Hospitals and Clinics
    • 7.1.1 Overview
    • 7.1.2 Hospitals and Clinics: Blood Gas and Electrolyte Analyzer Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Clinical and Diagnostic Laboratories
    • 7.2.1 Overview
    • 7.2.2 Clinical and Diagnostic Laboratories: Blood Gas and Electrolyte Analyzer Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Homecare
    • 7.3.1 Overview
    • 7.3.2 Homecare: Blood Gas and Electrolyte Analyzer Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Others
    • 7.4.1 Overview
    • 7.4.2 Others: Blood Gas and Electrolyte Analyzer Market - Revenue and Forecast to 2031 (US$ Million)

8. North America Blood Gas and Electrolyte Analyzer Market - Country Analysis

  • 8.1 North America
    • 8.1.1 North America: Blood Gas and Electrolyte Analyzer Market - Revenue and Forecast Analysis - by Country
      • 8.1.1.1 North America: Blood Gas and Electrolyte Analyzer Market - Revenue and Forecast Analysis - by Country
      • 8.1.1.2 United States: Blood Gas and Electrolyte Analyzer Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.1.2.1 United States: Blood Gas and Electrolyte Analyzer Market Breakdown, by Product
        • 8.1.1.2.2 United States: Blood Gas and Electrolyte Analyzer Market Breakdown, by End User
      • 8.1.1.3 Canada: Blood Gas and Electrolyte Analyzer Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.1.3.1 Canada: Blood Gas and Electrolyte Analyzer Market Breakdown, by Product
        • 8.1.1.3.2 Canada: Blood Gas and Electrolyte Analyzer Market Breakdown, by End User
      • 8.1.1.4 Mexico: Blood Gas and Electrolyte Analyzer Market - Revenue and Forecast to 2031 (US$ Million)
        • 8.1.1.4.1 Mexico: Blood Gas and Electrolyte Analyzer Market Breakdown, by Product
        • 8.1.1.4.2 Mexico: Blood Gas and Electrolyte Analyzer Market Breakdown, by End User

9. Industry Landscape

  • 9.1 Overview
  • 9.2 Organic Growth Strategies
    • 9.2.1 Overview
  • 9.3 Brand Share/Revenue- 2022

10. Company Profiles

  • 10.1 Abbott Laboratories
    • 10.1.1 Key Facts
    • 10.1.2 Business Description
    • 10.1.3 Products and Services
    • 10.1.4 Financial Overview
    • 10.1.5 SWOT Analysis
    • 10.1.6 Key Developments
  • 10.2 Dalko Diagnostics Private Limited
    • 10.2.1 Key Facts
    • 10.2.2 Business Description
    • 10.2.3 Products and Services
    • 10.2.4 Financial Overview
    • 10.2.5 SWOT Analysis
    • 10.2.6 Key Developments
  • 10.3 Erba Diagnostics Mannheim GmbH
    • 10.3.1 Key Facts
    • 10.3.2 Business Description
    • 10.3.3 Products and Services
    • 10.3.4 Financial Overview
    • 10.3.5 SWOT Analysis
    • 10.3.6 Key Developments
  • 10.4 Hoffmann-La Roche Ltd
    • 10.4.1 Key Facts
    • 10.4.2 Business Description
    • 10.4.3 Products and Services
    • 10.4.4 Financial Overview
    • 10.4.5 SWOT Analysis
    • 10.4.6 Key Developments
  • 10.5 Medica Corporation
    • 10.5.1 Key Facts
    • 10.5.2 Business Description
    • 10.5.3 Products and Services
    • 10.5.4 Financial Overview
    • 10.5.5 SWOT Analysis
    • 10.5.6 Key Developments
  • 10.6 Nova Biomedical Corporation
    • 10.6.1 Key Facts
    • 10.6.2 Business Description
    • 10.6.3 Products and Services
    • 10.6.4 Financial Overview
    • 10.6.5 SWOT Analysis
    • 10.6.6 Key Developments
  • 10.7 Siemens Healthineers AG
    • 10.7.1 Key Facts
    • 10.7.2 Business Description
    • 10.7.3 Products and Services
    • 10.7.4 Financial Overview
    • 10.7.5 SWOT Analysis
    • 10.7.6 Key Developments
  • 10.8 Werfen SA
    • 10.8.1 Key Facts
    • 10.8.2 Business Description
    • 10.8.3 Products and Services
    • 10.8.4 Financial Overview
    • 10.8.5 SWOT Analysis
    • 10.8.6 Key Developments
  • 10.9 Radiometer Medical ApS
    • 10.9.1 Key Facts
    • 10.9.2 Business Description
    • 10.9.3 Products and Services
    • 10.9.4 Financial Overview
    • 10.9.5 SWOT Analysis
    • 10.9.6 Key Developments
  • 10.10 Sensa Core Medical Instrumentation Pvt Ltd
    • 10.10.1 Key Facts
    • 10.10.2 Business Description
    • 10.10.3 Products and Services
    • 10.10.4 Financial Overview
    • 10.10.5 SWOT Analysis
    • 10.10.6 Key Developments

11. Appendix

  • 11.1 About The Insight Partners
  • 11.2 Glossary of Terms
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦